Contact Us
De-Identified Health Data Global Market Report 2025
Global De-Identified Health Data Market Report 2025
Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

De-Identified Health Data Global Market Report 2025

By Type (Clinical Data, Genomic Data, Patient Demographics, Prescription Data, Hospital And Provider Data, Pharmacogenomic Data); By End-User (Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers, Insurance Companies Or Healthcare Payers, Research Institutions, Government Agencies, Other End-Users); Subsegments:; By Clinical Data (Electronic Health Records, Medical Imaging Data, Laboratory Test Results); By Prescription Data (Medication Orders, Dosage Information, Prescription Refill History, Drug Allergies, Pharmacy Dispensation Records); By Pharmacogenomic Data (Gene–Drug Interaction Data, Adverse Drug Reaction Data, Personalized Therapy Response Data, Drug Efficacy Variation Data) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

De-Identified Health Data Market Overview

• De-Identified Health Data market size has reached to $8.20 billion in 2024

• Expected to grow to $14.40 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%

• Growth Driver: The Rising Adoption Of Electronic Health Records Is Driving The Growth Of The Market Due To Enhanced Patient Care, Secure Data Sharing, And Advanced Analytics

• Market Trend: Development In Real-World Biomarker Coverage Applications Driving Evidence-Based Healthcare Insights

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under De-Identified Health Data Market?

De-identified health data refers to patient information from which all personally identifiable details, such as names, addresses, and social security numbers, have been removed, making it impossible to link the data to any individual. It allows healthcare providers, researchers, and organizations to analyze trends, enhance treatments, and design effective public health strategies while protecting patient privacy.

The main types of de-identified health data are clinical data, genomic data, patient demographics, prescription data, hospital and provider data, and pharmacogenomic data. Clinical data refers to health-related information about a patient that is collected during the course of healthcare delivery, including medical history, diagnoses, treatments, laboratory results, and outcomes. This service is applied across diverse areas, including clinical research and trials, public health, precision medicine, health economics and outcomes research (HEOR), population health management, drug discovery and development, healthcare quality improvement, insurance underwriting and risk assessment, and others and caters to various end users, including pharmaceutical companies, biotechnology firms, healthcare providers, insurance companies or healthcare payers, research institutions, government agencies, and others.

De-Identified Health Data Market Size and growth rate 2025 to 2029: Graph

What Is The De-Identified Health Data Market Size 2025 And Growth Rate?

The de-identified health data market size has grown rapidly in recent years. It will grow from $8.20 billion in 2024 to $9.20 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to growing adoption of electronic health records, rising awareness of patient data privacy, a surge in healthcare analytics usage, increasing research on population health management, expansion of health information technology systems, and growing use of data in clinical trials.

What Is The De-Identified Health Data Market Growth Forecast?

The de-identified health data market size is expected to see rapid growth in the next few years. It will grow to $14.40 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to expanding use of artificial intelligence in healthcare, rising demand for real-world evidence in drug development, rising focus on secondary use of health data, a surge in demand for privacy-enhancing technology, and growing demand for precision medicine. Major trends in the forecast period include developing data privacy protocols, developing machine learning pipelines, integrating with electronic health records, integrating with population health platforms, and innovation in data anonymization techniques.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How the De-Identified Health Data Market Segmented?

1) By Type: Clinical Data, Genomic Data, Patient Demographics, Prescription Data, Hospital And Provider Data, Pharmacogenomic Data

2) By Application: Clinical Research And Trials, Public Health, Precision Medicine, Health Economics And Outcomes Research (HEOR), Population Health Management, Drug Discovery And Development, Healthcare Quality Improvement, Insurance Underwriting And Risk Assessment, Other Applications

3) By End-User: Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers, Insurance Companies Or Healthcare Payers, Research Institutions, Government Agencies, Other End-Users

Subsegments:

1) By Clinical Data: Electronic Health Records, Medical Imaging Data, Laboratory Test Results, Surgical Reports, Pathology Reports, Vital Signs Measurements

2) By Genomic Data: Whole Genome Sequencing Data, Exome Sequencing Data, Single Nucleotide Polymorphism Data, Gene Expression Profiles, Epigenetic Data

3) By Patient Demographics: Age Information, Gender Information, Ethnicity Information, Geographic Location, Socioeconomic Status, Marital Status

4) By Prescription Data: Medication Orders, Dosage Information, Prescription Refill History, Drug Allergies, Pharmacy Dispensation Records

5) By Hospital And Provider Data: Provider Performance Metrics, Care Delivery Outcomes, Billing And Claims Data, Resource Utilization Data

6) By Pharmacogenomic Data: Gene–Drug Interaction Data, Adverse Drug Reaction Data, Personalized Therapy Response Data, Drug Efficacy Variation Data

What Is Driving The De-Identified Health Data Market? The Rising Adoption Of Electronic Health Records Is Driving The Growth Of The Market Due To Enhanced Patient Care, Secure Data Sharing, And Advanced Analytics

The increasing adoption of electronic health records (EHRs) is expected to propel the growth of the de-identified health data market going forward. Electronic health records (EHR) refer to a digital version of a patient’s comprehensive medical history, including diagnoses, treatments, medications, lab results, and other health information securely stored and shared across authorized healthcare providers. The adoption of electronic health records is increasing due to their ability to enhance patient care and safety through accurate, real-time access to comprehensive medical information. De-identified health data enhances electronic health records by enabling secure data sharing and advanced analytics while protecting patient privacy, ultimately improving clinical decision-making and healthcare outcomes. For instance, in June 2022, according to the Department of Health and Social Care, a UK-based government department, it is anticipated that by March 2025, all NHS trusts will have implemented electronic health records, an increase from the 90% adoption rate recorded in December 2023. Therefore, the rising adoption of electronic health records (EHRs) is driving the growth of the de-identified health data industry.

Who Are The Major Players In The Global De-Identified Health Data Market?

Major companies operating in the de-identified health data market are UnitedHealth Group Incorporated, Oracle Corporation, IQVIA Holdings Inc, ICON Public Limited Company, Datavant Inc, Premier Inc., iMerit Technology Services Pvt. Ltd., Tempus Labs Inc., Medidata Solutions Inc., Veradigm Inc., Flatiron Health, Merative LP, Komodo Health Inc., Shaip Inc., Truveta Inc., Evidation Health Inc., TriNetX Inc., Clarify Health Solutions Inc., Akrivia Health Ltd., Gradient Health Inc.

What Are The Key Trends Of The Global De-Identified Health Data Market? Development In Real-World Biomarker Coverage Applications Driving Evidence-Based Healthcare Insights

Major companies operating in the de-identified health data market are focusing on developing advanced solutions, such as real-world biomarker coverage applications, to support evidence-based healthcare decision-making. A real-world biomarker coverage application leverages de-identified patient data to monitor and assess biomarker patterns and effectiveness across diverse populations outside clinical trials, enabling researchers and healthcare providers to gain insights into treatment responses and disease trends. For instance, in July 2025, Datma Inc., a US-based healthcare technology company, launches the Federated Biomarker Explorer, a free application designed for pharmaceutical teams to quickly validate real-world biomarker coverage across Datma’s federated network of participating data contributors. The tool provides aggregate, cohort-level insights into biomarker presence, enabling teams to assess coverage quickly without the need for contracts or IT support. It also allows secure integration of users’ own data for overlap analysis and facilitates early-stage feasibility assessments with clinical and demographic filtering, helping validate whether datasets include the necessary patient populations before committing resources.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The De-Identified Health Data Market? Innovative Injectable Solutions For Safe And Effective Fat Reduction

In July 2025, Datavant Inc., a US-based health information technology company, acquired Aetion Inc. for an undisclosed amount. Through this acquisition, Datavant aims to enhance its real-world evidence (RWE) capabilities by integrating Aetion's advanced analytics platform, thereby offering life sciences and healthcare organizations an end-to-end solution for generating regulatory-grade insights from de-identified health data. Aetion, Inc., is a US-based real-world evidence (RWE) platform that offers de-identified health data services through platforms such as Aetion Generate.

What Is The Regional Outlook For The Global De-Identified Health Data Market?

North America was the largest region in the de-identified health data market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the De-Identified Health Data Market?

The de-identified health data market includes revenues earned by entities by providing services such as medical research and clinical studies, machine learning development, public health and epidemiology, healthcare system improvement, and health economics and policy planning. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the De-Identified Health Data Industry?

The de-identified health data market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the de-identified health data industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Table Of Contents

1. Executive Summary

2. De-Identified Health Data Market Characteristics

3. De-Identified Health Data Market Trends And Strategies

4. De-Identified Health Data Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global De-Identified Health Data Growth Analysis And Strategic Analysis Framework

5.1. Global De-Identified Health Data PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global De-Identified Health Data Market Growth Rate Analysis

5.4. Global De-Identified Health Data Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global De-Identified Health Data Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global De-Identified Health Data Total Addressable Market (TAM)

6. De-Identified Health Data Market Segmentation

6.1. Global De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clinical Data

Genomic Data

Patient Demographics

Prescription Data

Hospital And Provider Data

Pharmacogenomic Data

6.2. Global De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clinical Research And Trials

Public Health

Precision Medicine

Health Economics And Outcomes Research (HEOR)

Population Health Management

Drug Discovery And Development

Healthcare Quality Improvement

Insurance Underwriting And Risk Assessment

Other Applications

6.3. Global De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmaceutical Companies

Biotechnology Firms

Healthcare Providers

Insurance Companies Or Healthcare Payers

Research Institutions

Government Agencies

Other End-Users

6.4. Global De-Identified Health Data Market, Sub-Segmentation Of Clinical Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Electronic Health Records

Medical Imaging Data

Laboratory Test Results

Surgical Reports

Pathology Reports

Vital Signs Measurements

6.5. Global De-Identified Health Data Market, Sub-Segmentation Of Genomic Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Whole Genome Sequencing Data

Exome Sequencing Data

Single Nucleotide Polymorphism Data

Gene Expression Profiles

Epigenetic Data

6.6. Global De-Identified Health Data Market, Sub-Segmentation Of Patient Demographics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Age Information

Gender Information

Ethnicity Information

Geographic Location

Socioeconomic Status

Marital Status

6.7. Global De-Identified Health Data Market, Sub-Segmentation Of Prescription Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Medication Orders

Dosage Information

Prescription Refill History

Drug Allergies

Pharmacy Dispensation Records

6.8. Global De-Identified Health Data Market, Sub-Segmentation Of Hospital And Provider Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Provider Performance Metrics

Care Delivery Outcomes

Billing And Claims Data

Resource Utilization Data

6.9. Global De-Identified Health Data Market, Sub-Segmentation Of Pharmacogenomic Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gene–Drug Interaction Data

Adverse Drug Reaction Data

Personalized Therapy Response Data

Drug Efficacy Variation Data

7. De-Identified Health Data Market Regional And Country Analysis

7.1. Global De-Identified Health Data Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global De-Identified Health Data Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific De-Identified Health Data Market

8.1. Asia-Pacific De-Identified Health Data Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China De-Identified Health Data Market

9.1. China De-Identified Health Data Market Overview

9.2. China De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India De-Identified Health Data Market

10.1. India De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan De-Identified Health Data Market

11.1. Japan De-Identified Health Data Market Overview

11.2. Japan De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia De-Identified Health Data Market

12.1. Australia De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia De-Identified Health Data Market

13.1. Indonesia De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea De-Identified Health Data Market

14.1. South Korea De-Identified Health Data Market Overview

14.2. South Korea De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe De-Identified Health Data Market

15.1. Western Europe De-Identified Health Data Market Overview

15.2. Western Europe De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK De-Identified Health Data Market

16.1. UK De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany De-Identified Health Data Market

17.1. Germany De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France De-Identified Health Data Market

18.1. France De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy De-Identified Health Data Market

19.1. Italy De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain De-Identified Health Data Market

20.1. Spain De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe De-Identified Health Data Market

21.1. Eastern Europe De-Identified Health Data Market Overview

21.2. Eastern Europe De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia De-Identified Health Data Market

22.1. Russia De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America De-Identified Health Data Market

23.1. North America De-Identified Health Data Market Overview

23.2. North America De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA De-Identified Health Data Market

24.1. USA De-Identified Health Data Market Overview

24.2. USA De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada De-Identified Health Data Market

25.1. Canada De-Identified Health Data Market Overview

25.2. Canada De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America De-Identified Health Data Market

26.1. South America De-Identified Health Data Market Overview

26.2. South America De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil De-Identified Health Data Market

27.1. Brazil De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East De-Identified Health Data Market

28.1. Middle East De-Identified Health Data Market Overview

28.2. Middle East De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa De-Identified Health Data Market

29.1. Africa De-Identified Health Data Market Overview

29.2. Africa De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. De-Identified Health Data Market Competitive Landscape And Company Profiles

30.1. De-Identified Health Data Market Competitive Landscape

30.2. De-Identified Health Data Market Company Profiles

30.2.1. UnitedHealth Group Incorporated Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Oracle Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.3. IQVIA Holdings Inc Overview, Products and Services, Strategy and Financial Analysis

30.2.4. ICON Public Limited Company Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Datavant Inc Overview, Products and Services, Strategy and Financial Analysis

31. De-Identified Health Data Market Other Major And Innovative Companies

31.1. Premier Inc.

31.2. iMerit Technology Services Pvt. Ltd.

31.3. Tempus Labs Inc.

31.4. Medidata Solutions Inc.

31.5. Veradigm Inc.

31.6. Flatiron Health

31.7. Merative LP

31.8. Komodo Health Inc.

31.9. Shaip Inc.

31.10. Truveta Inc.

31.11. Evidation Health Inc.

31.12. TriNetX Inc.

31.13. Clarify Health Solutions Inc.

31.14. Akrivia Health Ltd.

31.15. Gradient Health Inc.

32. Global De-Identified Health Data Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The De-Identified Health Data Market

34. Recent Developments In The De-Identified Health Data Market

35. De-Identified Health Data Market High Potential Countries, Segments and Strategies

35.1 De-Identified Health Data Market In 2029 - Countries Offering Most New Opportunities

35.2 De-Identified Health Data Market In 2029 - Segments Offering Most New Opportunities

35.3 De-Identified Health Data Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global De-Identified Health Data Market, Sub-Segmentation Of Clinical Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global De-Identified Health Data Market, Sub-Segmentation Of Genomic Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global De-Identified Health Data Market, Sub-Segmentation Of Patient Demographics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global De-Identified Health Data Market, Sub-Segmentation Of Prescription Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global De-Identified Health Data Market, Sub-Segmentation Of Hospital And Provider Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global De-Identified Health Data Market, Sub-Segmentation Of Pharmacogenomic Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global De-Identified Health Data Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global De-Identified Health Data Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: UnitedHealth Group Incorporated Financial Performance
  • Table 81: Oracle Corporation Financial Performance
  • Table 82: IQVIA Holdings Inc Financial Performance
  • Table 83: ICON Public Limited Company Financial Performance
  • Table 84: Datavant Inc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global De-Identified Health Data Market, Sub-Segmentation Of Clinical Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global De-Identified Health Data Market, Sub-Segmentation Of Genomic Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global De-Identified Health Data Market, Sub-Segmentation Of Patient Demographics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global De-Identified Health Data Market, Sub-Segmentation Of Prescription Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global De-Identified Health Data Market, Sub-Segmentation Of Hospital And Provider Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global De-Identified Health Data Market, Sub-Segmentation Of Pharmacogenomic Data, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global De-Identified Health Data Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global De-Identified Health Data Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, De-Identified Health Data Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, De-Identified Health Data Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, De-Identified Health Data Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: UnitedHealth Group Incorporated Financial Performance
  • Figure 81: Oracle Corporation Financial Performance
  • Figure 82: IQVIA Holdings Inc Financial Performance
  • Figure 83: ICON Public Limited Company Financial Performance
  • Figure 84: Datavant Inc Financial Performance

Frequently Asked Questions

De-identified health data refers to patient information from which all personally identifiable details, such as names, addresses, and social security numbers, have been removed, making it impossible to link the data to any individual. It allows healthcare providers, researchers, and organizations to analyze trends, enhance treatments, and design effective public health strategies while protecting patient privacy. For further insights on this market, request a sample here

The market major growth driver - The Rising Adoption Of Electronic Health Records Is Driving The Growth Of The Market Due To Enhanced Patient Care, Secure Data Sharing, And Advanced Analytics. For further insights on this market, request a sample here

The de-identified health data market size has grown rapidly in recent years. It will grow from $8.20 billion in 2024 to $9.20 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to growing adoption of electronic health records, rising awareness of patient data privacy, a surge in healthcare analytics usage, increasing research on population health management, expansion of health information technology systems, and growing use of data in clinical trials. The de-identified health data market size is expected to see rapid growth in the next few years. It will grow to $14.40 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to expanding use of artificial intelligence in healthcare, rising demand for real-world evidence in drug development, rising focus on secondary use of health data, a surge in demand for privacy-enhancing technology, and growing demand for precision medicine. Major trends in the forecast period include developing data privacy protocols, developing machine learning pipelines, integrating with electronic health records, integrating with population health platforms, and innovation in data anonymization techniques. For further insights on this market, request a sample here

The de-identified health data market covered in this report is segmented as
1) By Type: Clinical Data, Genomic Data, Patient Demographics, Prescription Data, Hospital And Provider Data, Pharmacogenomic Data
2) By Application: Clinical Research And Trials, Public Health, Precision Medicine, Health Economics And Outcomes Research (HEOR), Population Health Management, Drug Discovery And Development, Healthcare Quality Improvement, Insurance Underwriting And Risk Assessment, Other Applications
3) By End-User: Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers, Insurance Companies Or Healthcare Payers, Research Institutions, Government Agencies, Other End-Users Subsegments:
1) By Clinical Data: Electronic Health Records, Medical Imaging Data, Laboratory Test Results, Surgical Reports, Pathology Reports, Vital Signs Measurements
2) By Genomic Data: Whole Genome Sequencing Data, Exome Sequencing Data, Single Nucleotide Polymorphism Data, Gene Expression Profiles, Epigenetic Data
3) By Patient Demographics: Age Information, Gender Information, Ethnicity Information, Geographic Location, Socioeconomic Status, Marital Status
4) By Prescription Data: Medication Orders, Dosage Information, Prescription Refill History, Drug Allergies, Pharmacy Dispensation Records
5) By Hospital And Provider Data: Provider Performance Metrics, Care Delivery Outcomes, Billing And Claims Data, Resource Utilization Data
6) By Pharmacogenomic Data: Gene–Drug Interaction Data, Adverse Drug Reaction Data, Personalized Therapy Response Data, Drug Efficacy Variation Data For further insights on this market,
request a sample here

North America was the largest region in the de-identified health data market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in de-identified health data report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the de-identified health data market are UnitedHealth Group Incorporated, Oracle Corporation, IQVIA Holdings Inc, ICON Public Limited Company, Datavant Inc, Premier Inc., iMerit Technology Services Pvt. Ltd., Tempus Labs Inc., Medidata Solutions Inc., Veradigm Inc., Flatiron Health, Merative LP, Komodo Health Inc., Shaip Inc., Truveta Inc., Evidation Health Inc., TriNetX Inc., Clarify Health Solutions Inc., Akrivia Health Ltd., Gradient Health Inc. For further insights on this market, request a sample here.

Major trends in this market include Development In Real-World Biomarker Coverage Applications Driving Evidence-Based Healthcare Insights For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon